nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
|
Massy, Ziad A. |
|
|
4 |
11 |
p. 1546-1554 |
artikel |
2 |
Association Between Perfluoroalkyl Substance Exposure and Renal Function in Children With CKD Enrolled in H3Africa Kidney Disease Research Network
|
Sood, Shefali |
|
|
4 |
11 |
p. 1641-1645 |
artikel |
3 |
Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry
|
Rondeau, Eric |
|
|
4 |
11 |
p. 1568-1576 |
artikel |
4 |
Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis
|
Mendoza, Carmen E. |
|
|
4 |
11 |
p. 1617-1629 |
artikel |
5 |
Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies
|
Drachenberg, Cinthia B. |
|
|
4 |
11 |
p. 1555-1567 |
artikel |
6 |
Evaluation of Different Dialyzers and the Impact of Predialysis Albumin Priming in Intermittent Hemodialysis With Reduced Anticoagulation
|
Vanommeslaeghe, Floris |
|
|
4 |
11 |
p. 1538-1545 |
artikel |
7 |
Geographic Variation in the Availability of Deceased Donor Kidneys per Wait-Listed Candidate in the United States
|
King, Kristen L. |
|
|
4 |
11 |
p. 1630-1633 |
artikel |
8 |
Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
|
Barratt, Jonathan |
|
|
4 |
11 |
p. 1633-1637 |
artikel |
9 |
2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report
|
Wang, Angela Yee-Moon |
|
|
4 |
11 |
p. 1523-1537 |
artikel |
10 |
Membranous Glomerulonephritis With Crescents
|
Nikolopoulou, Aikaterini |
|
|
4 |
11 |
p. 1577-1584 |
artikel |
11 |
Predialysis Care Experience Among Patients With CKD at a Teaching Hospital in Kenya
|
Kabinga, Samuel K. |
|
|
4 |
11 |
p. 1638-1641 |
artikel |
12 |
Role of Liver Transplantation in Tolvaptan-Associated Acute Liver Failure
|
Endo, Mayumi |
|
|
4 |
11 |
p. 1653-1657 |
artikel |
13 |
Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification
|
Coyne, Daniel W. |
|
|
4 |
11 |
p. 1585-1597 |
artikel |
14 |
Spontaneous Renal Artery Dissection in Ehler–Danlos Syndrome
|
Emanuela, Cataldo |
|
|
4 |
11 |
p. 1649-1652 |
artikel |
15 |
Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney Disease
|
Oh, Gia J. |
|
|
4 |
11 |
p. 1608-1616 |
artikel |
16 |
The Authors Reply
|
Duval, Anna |
|
|
4 |
11 |
p. 1658-1659 |
artikel |
17 |
The Executive Order on Kidney Care: An Opportunity to Improve Outcomes for Individuals With Kidney Disease
|
Pearson, Jeffrey |
|
|
4 |
11 |
p. 1519-1522 |
artikel |
18 |
The Executive Order on Kidney Care: We Need to Do Much More to Win the Battle Against Kidney Disease
|
Handal, Janet |
|
|
4 |
11 |
p. 1515-1518 |
artikel |
19 |
Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS
|
Cheung, Chee Kay |
|
|
4 |
11 |
p. 1658 |
artikel |
20 |
Vascular Ehlers-Danlos Syndrome Diagnosed in a Patient Initiating Hemodialysis
|
Ouchi, Haruki |
|
|
4 |
11 |
p. 1646-1648 |
artikel |
21 |
Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
|
Bansal, Nisha |
|
|
4 |
11 |
p. 1598-1607 |
artikel |